Generic Drug Market Size, Share, Trends, Demand, Growth Forecast, Segmentation and Revenue Outlook

Published November 10, 2023

Generic Drug Market stands out as an unparalleled market research report, conducting in-depth industry analyses across global products, markets, companies, and countries. This comprehensive marketing report delves into specific stocks, currencies, commodities, and geographic regions. Meticulously crafted by a team of innovative researchers and analysts, it covers a wide range of parameters, including the latest trends, market segmentation, industry forecasting, target market analysis, and strategic insights. With a dedicated focus on the healthcare industry, Generic Drug Market provides valuable market insights, essential for navigating the competitive landscape. Global Generic Drug Market report offers advanced information and scenario about the HELATH industry which helps to stand apart in the competition in this fast paced business environment.

Data Bridge Market Research analyses that the generic drug market, which is USD 622.02 million in 2022, is expected to reach USD 1,323.68 million by 2030, at a CAGR of 9.9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @

The World Health Organization estimates that each year there are between 2 and 3 million instances of non-melanoma skin cancer and 132,000 cases of melanoma skin cancer. In addition, the prevalence of psoriasis in the world varies from 0.09 percent to 11.43%, making it a serious condition that affects at least 100 million people worldwide. The fact is that topical drug administration is the primary therapy method for most skin conditions, and the market for advanced topical products is projected to grow in the upcoming years.

Generic medications differ from branded drugs in several aspects, such as the manufacturing process utilized in drug development, excipients, and packaging. Still, they are bioequivalent to branded drugs in terms of strength, dose, quality, safety, performance, and efficacy. Generic drugs become available when the patents for already marketed medications expire. Generic medications, not associated with a particular manufacturer, are often controlled by governments worldwide.


  • Stringent regulations will hinders the growth

Stringent controls, as the FDA assesses the accuracy, side effects, and other substances used in generic pharmaceuticals, are one of the main factors limiting the expansion of generic drugs. Pharmaceutical drugs are typically recalled if the producers don’t follow the regulatory requirements. The key elements that influence the quality of generic drugs are purity, potency, stability, and drug release. These should be managed within an appropriate limit, range, or distribution to obtain the desired drug quality. As a result of the strict governmental rules, approval is needed for generic pharmaceuticals, which is projected to hinder market expansion.

This generic drug market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the generic drug market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In 2020, ANI Pharmaceuticals, Inc., a US-based integrated specialty pharmaceutical company focused on developing, producing, and marketing high-quality branded and generic prescription pharmaceuticals acquired Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd. for $52.5 million in cash. The deal has greatly increased ANI Pharmaceuticals, Inc’s commercial portfolio and late-stage generic pipeline.

Some of the major players operating in the generic drug market are:

  • Teva Pharmaceuticals Industries Ltd., (Israel)
  • Mylan NV, (US.)
  • Novartis AG, (Switzerland)
  • Pfizer Inc., (US.)
  • Sun Pharmaceutical Industries Ltd., (India)
  • Fresenius SE & Co. KGaA., (Germany)
  • Lupin (India)
  • Endo International plc., (Ireland)
  • Aurobindo Pharma (India)
  • Novartis AG (Switzerland)
  • Hikma Pharmaceuticals PLC., (UK.)
  • STADA Arzneimittel AG (Germany)
  • Eli Lilly and Company (US)
  • Aspen Holdings (South Africa)

To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@

Generic Drug Market Scope

The generic drug market is segmented on the basis of type, brand, indication, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.


  • Simple Generics
  • Super Generics


  • Pure Generic
  • Branded Generic


  • Central Nervous System (CNS)
  • Cardiovascular
  • Dermatology
  • Oncology
  • Respiratory
  • Others

Route of Administration

  • Oral
  • Topical
  • Parenteral
  • Others


  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Key Advantages of the Report: 

  • This study provides an analytical overview of the industry, including current trends and future predictions to identify potential investment opportunities.
  • The report offers insights into key drivers, limitations, and prospects, along with a comprehensive market share analysis.
  • The report quantitatively assesses the current market, shedding light on its growth prospects.
  • A Porter’s five forces analysis gauges the bargaining power of buyers and suppliers in the market.
  • The report delivers an in-depth market analysis that considers competitive dynamics and forecasts the future competitive landscape.

What to Anticipate from the Report – A 7-Point Guide:

  • The report delves into the holistic strategy and innovation within the market ecosystem.
  • It highlights prominent market drivers and obstacles, providing clarity on technological standardization and regulatory frameworks.
  • The report evaluates various implementation models and examines numerous use cases.
  • Serving as a valuable resource, the report offers essential industry insights, showcasing information on new investments, stakeholders, relevant contributors, and market participants.
  • Through the forecast period, the report conducts a thorough market analysis, referencing historical developments, ongoing events, and future growth prospects.

Top DBMR Healthcare Reports:         

Global Throat Cancer Diagnostics Market    

Europe Throat Cancer Diagnostics Market    

Asia-Pacific Throat Cancer Diagnostics Market    

Middle East and Africa Throat Cancer Diagnostics Market    

North America Throat Cancer Diagnostics Market    

Global Hip Replacement Implants Market    

Swiss Hip Replacement Implants Market    

Global Polymerase Chain Reaction Market    

U.S. Polymerase Chain Reaction Market    

U.S. Bioabsorbable Orthopedics Implants Market    

U.A.E Aesthetics/Cosmetics Market    

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475


CDN Newswire